封面
市場調查報告書
商品編碼
1984176

NGS資訊學市場:2026-2032年全球市場預測(按組件、技術、部署模式、工作流程類型、應用和最終用戶分類)

NGS Informatics Market by Component, Technology, Deployment Mode, Workflow Type, Application, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年,NGS 資訊學市場價值將達到 410.2 億美元,到 2026 年將成長至 488.6 億美元,年複合成長率為 22.08%,到 2032 年將達到 1,658.3 億美元。

主要市場統計數據
基準年 2025 410.2億美元
預計年份:2026年 488.6億美元
預測年份 2032 1658.3億美元
複合年成長率 (%) 22.08%

簡要概述為什麼次世代定序資訊學現在是研究、診斷和生物技術組織策略運作的基礎。

次世代定序資訊學目前正處於三大因素的交會點:科技的快速創新、臨床領域的廣泛應用以及日益嚴格的監管。隨著定序處理能力的不斷提升及其應用範圍從基礎研究擴展到臨床診斷,資訊學已從單純的輔助功能演變為一項策略差異化因素。本文概述了決策者在將資訊學投資與組織目標相契合時必須面對的核心功能、新挑戰和實際操作問題。

計算技術的進步、雲端運算的成熟、監管的加強以及勞動力的轉型是如何相互交織,從而重新定義 NGS 資訊學的價值鍊和競爭格局的?

在技​​術、監管和商業性因素的共同推動下,新一代定序(NGS)資訊學領域正經歷著一場變革。包括機器學習和基於圖的方法在內的演算法方法的進步,顯著提高了變異檢測、註釋準確性和解讀能力,從而能夠對複雜的基因組訊號進行更深入的解讀。同時,長讀長定定序和單細胞定序技術正在拓展資訊學必須應對的生物學挑戰範圍,這要求建構能夠處理更高維度和更豐富元元資料的架構。

一項基於證據的審查,旨在探討 2025 年關稅將如何改變供應鏈策略、採購模式以及定序和資訊學領域所有相關人員的營運規劃。

美國將於2025年實施關稅,這為依賴進口硬體、試劑和專用資訊設備的機構的採購和營運規劃帶來了結構性複雜性。雖然關稅主要針對有形資產,但其連鎖反應會波及軟體驅動的工作流程,增加邊緣運算、定序設備和託管基礎設施部署相關的資本和營運成本。因此,採購團隊現在更加嚴格地評估總體擁有成本 (TCO),並將不斷上漲的進口關稅、波動的運輸成本以及海關延誤等因素考慮在內。

細分領域的洞察揭示了應用程式需求、元件角色、最終用戶需求、技術選擇、部署偏好和工作流程階段如何共同決定資訊科學的優先事項。

要精準了解市場,需要基於細分市場的洞察,這些洞察應反映出各個應用的具體需求、組件角色、最終用戶需求、技術層級、部署偏好和工作流程階段。應用主導的需求在癌症研究、遺傳疾病研究、感染疾病研究和生殖健康項目等領域各不相同。即使在癌症研究領域,由於突變譜分析和臨床解讀需求的差異,分析也必須區分血液系統惡性腫瘤(造血系統癌症)和固態腫瘤。感染疾病應用也呈現其獨特的差異。細菌基因組學工作流程優先考慮基因組組裝和抗生素抗藥性檢測,而病毒基因組學則強調快速建立共識序列和系統發育分析。生殖醫學應用涵蓋從親子鑑定到產前篩檢的各個方面,每項應用都需要特定的靈敏度和報告標準。

美洲、歐洲、中東和非洲以及亞太地區的區域法規結構、基礎設施成熟度和投資模式如何塑造 NGS 資訊學的採用和採購的獨特路徑。

區域趨勢對資訊學應用模式、監管立場和投資重點有顯著影響,美洲、歐洲、中東和非洲(EMEA)以及亞太地區呈現不同的特徵。在美洲,強勁的私營部門投資、成熟的雲端生態系以及緊密的參考檢查室網路正在推動先進資訊學平台的快速普及。然而,不同司法管轄區的監管差異以及近期的關稅環境使得謹慎選擇供應商和對沖供應鏈風險變得至關重要。此外,美洲正在建構一個充滿活力的產學研轉化平台,以支持實驗性資訊學方法與商業平台的早期應用。

供應商的策略行動、夥伴關係模式和能力組合定義了序列資訊學生態系統中的競爭結構和買方決策標準。

生物資訊學領域的競爭格局由眾多參與者構成,包括成熟的企業軟體供應商、專業的生物資訊工具供應商、雲端超大規模資料中心業者服務商、正在拓展軟體生態系統的定序平台製造商,以及專注於小眾、高價值應用場景的敏捷型Start-Ups。成熟的供應商提供整合套件、檢驗支援和企業級服務等級協定 (SLA),因此對重視合規性和供應商課責的醫院和大型製藥企業極具吸引力。同時,專業的工具提供者和Start-Ups往往在分析方法、視覺化和使用者體驗方面創新速度更快,通常致力於解決結構突變識別、單細胞數據分析或互動式隊列探索等特定挑戰。

為了確保長期的競爭優勢,營運經理和主管現在可以採取具體措施,以建立具有彈性的供應鏈、可擴展的資訊架構和人才能力。

尋求競爭優勢的領導者應優先採取一系列切實可行的措施來應對短期營運風險,同時確保能力建設投資與業務目標保持一致。首先,應實現供應鏈多元化,並協商制定足夠靈活的採購契約,以應對關稅波動和交貨中可能出現的意外情況。此外,在適當情況下,應考慮採用租賃或訂閱模式採購資本設備,以減輕前期成本負擔。其次,應投資於混合雲端架構和容器化、工作流程定義的管道,以提高可攜性、可複現性和成本控制,同時確保建立資料管治框架,以管理跨境資料流和合規義務。

我們採用了一種綜合性的混合方法,結合文獻整合、相關人員訪談、專家檢驗和迭代品管,以確保研究結果基於證據。

本分析的調查方法結合了多方面的證據、專家諮詢和結構化檢驗,以確保得出可靠且可操作的見解。該方法首先對技術文獻、供應商文件、監管指南和同行評審的研究進行了全面審查,以了解當前的技術能力和調查方法趨勢。此外,還對包括生物資訊學家、實驗室經理、採購經理、供應商高階主管和臨床終端使用者在內的各類相關人員進行了一系列深入訪談,以了解實際營運和策略意圖。

策略整合凸顯了模組化架構、人才投資和強大的採購系統對於釋放 NGS 資訊學的全部潛力至關重要。

總之,次世代定序的資訊層已從營運成本轉變為影響科學成果、臨床路徑和商業性競爭的策略資產。諸如演算法改進、雲端原生架構和更豐富的定序方法等技術進步拓展了應用前景,但也增加了管治、檢驗和人才需求的複雜性。關稅的引入和不斷變化的區域環境進一步加劇了採購和部署決策的複雜性,凸顯了靈活採購模式和穩健情境規劃的必要性。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

第8章 NGS資訊學市場:按組件分類

  • 服務
    • 客戶服務
    • 訂閱服務
  • 軟體工具
    • 資料管理工具
    • 序列資料分析工具
    • 視覺化工具

第9章 NGS資訊學市場:依技術分類

  • 數據分析
    • 比對和映射
    • 註記與解釋
    • 變體調用
  • 資料管理
    • 電子資料擷取系統
    • 檢查資訊管理系統
  • 資料閘道器
    • 雲端儲存
    • 本地儲存

第10章:NGS資訊學市場:依部署模式分類

    • 私有雲端
    • 公共雲端
  • 現場

第11章 依工作流程類型分類的NGS資訊學市場

  • 初步分析
    • 基地識別
    • 影像處理
  • 二次分析
    • 結盟
    • 品管
    • 變體調用
  • 三級分析
    • 資料探勘
    • 報告創建和可視化

第12章 NGS 資訊學市場:按應用分類

  • 癌症調查
    • 血癌
    • 固體癌
  • 遺傳疾病調查
  • 感染疾病
    • 細菌基因體學
    • 病毒基因組學
  • 生殖醫學
    • 親子鑑定
    • 產前篩檢

第13章 NGS 資訊學市場:依最終使用者分類

  • 學術研究機構
    • 私人研究機構
    • 公立大學
  • 合約研究機構
  • 醫療保健提供者
    • 診斷檢測實驗室
    • 醫院
  • 製藥和生物技術公司
    • 大型製藥企業
    • 中小型生技公司

第14章 NGS 資訊學市場:按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 NGS 資訊學市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 NGS 資訊學市場:按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章:美國NGS資訊學市場

第18章:中國NGS資訊市場

第19章 競爭情勢

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年
  • Agilent Technologies Inc.
  • Azenta Life Sciences
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Dassault Systemes
  • Dnanexus Inc.
  • DNASTAR Inc.
  • Eagle Genomics Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Fabric Genomics Inc.
  • Genedata AG
  • IBM Corporation
  • Illumina, Inc.
  • Partek Incorporated
  • PerkinElmer, Inc
  • PerkinElmer, Inc.
  • PierianDx, Inc.
  • Qiagen NV
  • Real Time Genomics Inc.
  • Roche Diagnostics International AG
  • Sapio Sciences
  • SoftGenetics, LLC
  • Thermo Fischer Scientific Inc.
Product Code: MRR-5C6F41F5AFE9

The NGS Informatics Market was valued at USD 41.02 billion in 2025 and is projected to grow to USD 48.86 billion in 2026, with a CAGR of 22.08%, reaching USD 165.83 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 41.02 billion
Estimated Year [2026] USD 48.86 billion
Forecast Year [2032] USD 165.83 billion
CAGR (%) 22.08%

A concise orientation to why next-generation sequencing informatics now acts as a strategic operational backbone for research, diagnostics, and biotechnology organizations

Next-generation sequencing informatics now sits at the intersection of rapid technological innovation, expanding clinical adoption, and intensifying regulatory scrutiny. As sequencing throughput continues to increase and the diversity of applications broadens from basic research to clinical diagnostics, informatics has evolved from a supporting capability into a strategic differentiator. This introduction outlines the core functions, emergent pressures, and the operational realities that decision-makers must confront when aligning informatics investments with organizational objectives.

Across research institutions, clinical laboratories, and biotech firms, informatics pipelines are no longer optional back-end utilities; they are mission-critical systems that must deliver traceable, reproducible, and interpretable results at scale. The operational demands include processing ever-larger volumes of raw reads, integrating multi-omic datasets, and ensuring secure, compliant storage and access. In parallel, stakeholders face challenges related to skills shortages, heterogeneous data formats, and varying levels of cloud readiness. These constraints shape procurement, vendor selection, and internal capability-building.

This introductory overview frames subsequent sections by distilling why informatics investments matter now: they affect time-to-insight for research programs, the accuracy and reproducibility of clinical reports, and the cost structure of sequencing operations. By establishing this baseline, the reader can better appreciate the strategic trade-offs between custom-built pipelines and commercial platforms, the importance of modularity and interoperability, and the need for robust governance frameworks that span data management, security, and regulatory compliance.

How computational advances, cloud maturity, regulatory scrutiny, and workforce evolution are converging to redefine the NGS informatics value chain and competitive dynamics

The landscape of NGS informatics is undergoing transformative shifts driven by converging technological, regulatory, and commercial forces. Advances in algorithmic approaches, including machine learning and graph-based methods, have materially improved variant detection, annotation accuracy, and interpretive throughput, enabling more nuanced interpretation of complex genomic signals. Concurrently, long-read sequencing and single-cell approaches are expanding the types of biological questions that informatics must support, prompting architectures that can handle higher dimensionality and richer metadata.

Cloud adoption has matured from experimental pilots to production deployments, changing the economics of compute and storage while elevating concerns around data sovereignty, latency, and cost predictability. Standardization efforts are gaining momentum, with the community increasingly focusing on exchange formats, APIs, and reproducible workflow specifications to reduce friction across platforms and institutions. This drive toward interoperability is complemented by a marketplace shift: open-source toolchains coexist with commercial platforms, and hybrid models that combine managed services with extensible software suites are becoming the norm.

At the same time, regulatory and payer attention on clinical sequencing has increased, leading to greater emphasis on validation, auditability, and explainability of analytic pipelines. These pressures encourage investments in provenance tracking, version control, and certified workflows. Finally, talent dynamics are changing; the demand for bioinformaticians with cloud engineering, data science, and software development skills is increasing, incentivizing investments in training and collaborative partnerships. Collectively, these shifts are reshaping procurement decisions, partnership strategies, and internal capability roadmaps across the sector.

An evidence-based review of how the 2025 tariffs have reshaped supply chain strategies, procurement models, and operational planning across sequencing informatics stakeholders

The imposition of tariffs in the United States in 2025 has introduced a layer of structural complexity to procurement and operational planning for organizations that depend on imported hardware, reagents, and specialized informatics appliances. Although tariffs primarily target tangible goods, the downstream effects permeate software-enabled workflows by increasing the capital and operational costs associated with deploying edge compute, sequencing instruments, and co-located infrastructure. Procurement teams are consequently evaluating total cost of ownership more rigorously, accounting for elevated import duties, shipping variability, and customs-related delays.

One immediate consequence is a reorientation toward localized sourcing strategies and strategic inventory buffering to mitigate supply disruptions. Laboratories and service providers have begun reassessing supplier portfolios, prioritizing partners with resilient manufacturing footprints or regional distribution hubs that minimize tariff exposure. For vendors, tariffs have accelerated conversations about regional assembly, device redesign to use components sourced from lower-tariff jurisdictions, and revisiting pricing models to absorb or pass through new costs.

The cumulative impact extends to collaborations and contract structures. Contract research organizations and academic consortia are renegotiating terms to include tariff risk-sharing clauses, adjusting timelines for capital-intensive projects, and exploring lease or subscription models for equipment to dampen upfront tariff-driven expense shocks. Additionally, tariff-driven cost pressures are prompting some stakeholders to prioritize software-centric optimizations-improving data compression, computational efficiency, and cloud-native practices-to offset higher hardware-related costs. Taken together, these developments are forcing a re-evaluation of supply chain resilience, procurement policy, and long-term investment priorities across the NGS informatics ecosystem.

Segment-level intelligence revealing how application needs, component roles, end-user requirements, technology choices, deployment preferences, and workflow stages collectively determine informatics priorities

A nuanced understanding of the market requires segmentation-based insight that reflects distinct application needs, component roles, end-user demands, technological layers, deployment preferences, and workflow stages. Application-driven requirements vary across cancer research, genetic disorder research, infectious disease work, and reproductive health programs, and within cancer research the analytics must distinguish between hematologic cancers and solid tumors because of differing variant profiles and clinical interpretation needs. Infectious disease applications present their own bifurcation: bacterial genomics workflows prioritize assembly and antimicrobial resistance detection while viral genomics focus on rapid consensus generation and phylogenetics; reproductive health applications span paternity testing and prenatal screening, each demanding specific sensitivity and reporting conventions.

Component segmentation highlights the divergence between services and software tools. Services encompass custom offerings tailored to specific study designs and subscription services that provide continuous support and updates, whereas software tools include data management platforms, sequencing data analysis suites, and visualization instruments which together form the operational backbone for data ingestion, processing, and interpretation. End users display differentiated buying behaviors and capability expectations: academic and research institutions, including private research institutes and public universities, often prioritize flexibility and methodological transparency; contract research organizations, split across clinical and preclinical CROs, emphasize throughput and validated workflows; healthcare providers, from diagnostic laboratories to hospitals, require compliance, turn-key integration, and reproducible clinical reporting; and pharmaceutical and biotechnology companies, whether large pharma or small biotech, combine requirements for security, scalability, and regulatory-grade validation.

Technology-level segmentation further clarifies buyer priorities by distinguishing data analysis, which includes alignment, annotation, and variant calling subfunctions, from data management solutions such as electronic data capture and laboratory information management systems, and data storage choices between cloud and on-premise modalities. Deployment mode choices pivot on cloud or on-premise architectures, with cloud options subdivided into private and public clouds and on-premise solutions ranging from co-located data centers to in-house installations, each presenting distinct trade-offs in cost, control, latency, and compliance. Finally, workflow segmentation across primary, secondary, and tertiary analysis stages underscores the operational sequence from base calling and image processing to alignment, quality control, variant calling, and onwards to data mining and reporting. Integrating these segment perspectives reveals where value accrues, where integration challenges persist, and which combinations of offerings best meet the requirements of different stakeholder cohorts.

How regional regulatory frameworks, infrastructure maturity, and investment patterns in the Americas, EMEA, and Asia-Pacific shape distinct pathways for NGS informatics adoption and procurement

Regional dynamics exert a strong influence on informatics adoption patterns, regulatory posture, and investment priorities, with distinct profiles emerging across the Americas, Europe Middle East and Africa, and Asia-Pacific regions. In the Americas, strong private-sector investment, a mature cloud ecosystem, and a dense network of reference laboratories facilitate rapid adoption of advanced informatics platforms, though regulatory variability between jurisdictions and the recent tariff environment prompt careful vendor selection and supply chain hedging. The Americas also feature active translational pipelines between academic centers and industry, supporting early adoption of experimental informatics methods alongside commercial platforms.

In Europe, the Middle East and Africa, regulatory harmonization efforts, and robust public health initiatives shape demand, with many organizations prioritizing data sovereignty, stringent privacy compliance, and hybrid deployment architectures. Interoperability and standardization are prominent themes, as pan-regional health initiatives incentivize shared formats and APIs. In the Middle East and Africa specifically, infrastructure gaps and uneven access to skilled bioinformatics personnel create opportunities for managed services and training partnerships that bridge capability shortfalls.

The Asia-Pacific region is characterized by a rapidly expanding base of sequencing facilities, growing domestic manufacturing capabilities, and aggressive public and private R&D investments. Cloud adoption varies across markets, but where it is mature, it supports high-throughput sequencing programs and large-scale population genomics initiatives. Across all regions, local regulatory frameworks, reimbursement policies, and talent availability will continue to shape procurement decisions and the relative appeal of cloud-native versus on-premise solutions, emphasizing the need for region-specific go-to-market strategies and partnership models.

Strategic vendor behaviors, partnership models, and capability portfolios that define the competitive contours of the sequencing informatics ecosystem and buyer decision criteria

The competitive landscape in informatics is defined by a spectrum of players that include established enterprise software vendors, specialist bioinformatics tool providers, cloud hyperscalers, sequencing platform manufacturers extending into software ecosystems, and nimble start-ups focused on narrow, high-value use cases. Established vendors bring integrated suites, validation support, and enterprise-grade SLAs, making them attractive to hospitals and large pharmaceutical companies that prioritize compliance and vendor accountability. Specialist tool providers and start-ups tend to innovate faster in analytics methods, visualization, and user experience, often addressing specific pain points such as structural variant calling, single-cell interpretation, or interactive cohort exploration.

Cloud providers play a dual role: they supply scalable compute and storage and increasingly offer managed genomics services that package best-practice workflows, security controls, and billing models. This has shifted vendor engagement models, enabling partnerships where platform vendors embed cloud-native services while retaining the option for hybrid or on-premise deployments. Meanwhile, service-oriented organizations-including CROs and managed service providers-differentiate through domain expertise, throughput guarantees, and regulatory compliance support, often serving as the bridge for institutions that lack in-house informatics capabilities.

Across the ecosystem, strategic behaviors such as vertical integration, partnership ecosystems, and M&A are evident. Companies that combine strong algorithmic IP with robust deployment and validation capabilities command attention from enterprise buyers. Open-source projects remain a vital source of innovation and community validation, and vendors that balance openness with enterprise support often enjoy broader adoption. For buyers, vendor evaluation should emphasize roadmap transparency, support for standards, interoperability, and demonstrable validation across relevant use cases.

Actionable steps that operational leaders and executives can implement now to build resilient supply chains, scalable informatics architectures, and workforce capabilities for long-term advantage

Leaders seeking to secure a competitive advantage should prioritize a set of pragmatic actions that align capability investments with business objectives while addressing near-term operational risks. First, diversify the supply chain and negotiate procurement contracts that include flexibility for tariff fluctuations and delivery contingencies; consider lease or subscription models for capital equipment where appropriate to reduce upfront exposure. Second, invest in hybrid cloud architectures and containerized, workflow-defined pipelines to improve portability, reproducibility, and cost control, while ensuring that data governance frameworks are in place to manage cross-border flows and compliance obligations.

Third, accelerate workforce development by combining targeted hiring with internal training programs that blend bioinformatics, cloud engineering, and software development skills; partnerships with academic institutions and targeted internships can help build a steady talent pipeline. Fourth, adopt standards-based APIs and provenance-tracking mechanisms to facilitate interoperability, reduce vendor lock-in, and simplify regulatory validation. Fifth, engage in strategic partnerships and alliances that augment internal capabilities-collaborations with CROs, specialist analytics vendors, and managed service providers can deliver immediate capacity and validated workflows.

Finally, incorporate tariff and geopolitical risk into scenario planning and R&D prioritization, and maintain an active dialogue with policymakers to communicate the downstream impacts of trade policies on research and clinical services. By pursuing these actions, organizations can reduce operational fragility, accelerate time-to-insight, and create a more defensible position in an increasingly competitive and regulated environment.

A comprehensive mixed-methods research approach combining literature synthesis, stakeholder interviews, expert validation, and iterative quality controls to ensure evidence-based insights

The research methodology underpinning this analysis combined multi-source evidence, expert consultation, and structured validation to ensure robust, actionable findings. The approach began with a comprehensive review of technical literature, vendor documentation, regulatory guidance, and peer-reviewed studies to map current technological capabilities and methodological trends. This secondary analysis was complemented by a series of in-depth interviews with a diverse set of stakeholders, including bioinformaticians, laboratory directors, procurement leads, vendor executives, and clinical end users, to capture operational realities and strategic intent.

Quantitative and qualitative data were synthesized to create segmentation frameworks that align application needs, technology choices, deployment preferences, and workflow stages. Validation workshops with domain experts were conducted to stress-test assumptions, refine taxonomy definitions, and ensure that regional nuances were accurately reflected. Quality controls included cross-referencing primary interview claims against published protocols and vendor technical specifications, anonymized triangulation of reported behaviors, and iterative review cycles to resolve discrepancies.

The methodology emphasized transparency and traceability: all key assertions are supported by documented sources or attributed expert input, and limitations are acknowledged where data gaps exist. Where necessary, conservative judgement was applied to reconcile conflicting inputs, and sensitivity checks were performed to assess how alternative assumptions might influence strategic recommendations. This mixed-methods approach ensures that the insights presented are both evidence-based and practically grounded.

A strategic synthesis that underscores why modular architectures, workforce investment, and resilient procurement are essential to realize the full potential of NGS informatics

In conclusion, the informatics layer of next-generation sequencing has transitioned from an operational expense to a strategic asset that shapes scientific outcomes, clinical pathways, and commercial competitiveness. Technological advances, including improved algorithms, cloud-native architectures, and richer sequencing modalities, are expanding what is possible, but they also increase complexity in governance, validation, and workforce requirements. The imposition of tariffs and evolving regional dynamics further complicate procurement and deployment decisions, underscoring the need for flexible sourcing models and robust scenario planning.

Success in this environment will depend on the ability to marry technical excellence with pragmatic operational design: prioritize modular, standards-based architectures that can evolve with new analytical techniques; build partnerships that supplement internal capabilities while preserving control of core intellectual property; and invest in workforce development to bridge the gap between domain expertise and software engineering. Organizations that adopt these principles will be better positioned to extract value from sequencing data, accelerate translational research, and deliver clinically actionable insights with confidence.

Ultimately, the path forward is not a single blueprint but a set of strategic choices that reflect each organization's risk tolerance, regulatory obligations, and mission. By understanding the segmentation dynamics, regional considerations, and vendor landscape, leaders can make informed decisions that balance innovation with reliability and cost-effectiveness.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. NGS Informatics Market, by Component

  • 8.1. Services
    • 8.1.1. Custom Services
    • 8.1.2. Subscription Services
  • 8.2. Software Tools
    • 8.2.1. Data Management Tools
    • 8.2.2. Sequencing Data Analysis Tools
    • 8.2.3. Visualization Tools

9. NGS Informatics Market, by Technology

  • 9.1. Data Analysis
    • 9.1.1. Alignment And Mapping
    • 9.1.2. Annotation And Interpretation
    • 9.1.3. Variant Calling
  • 9.2. Data Management
    • 9.2.1. Electronic Data Capture Systems
    • 9.2.2. Laboratory Information Management Systems
  • 9.3. Data Storage
    • 9.3.1. Cloud Storage
    • 9.3.2. On-Premise Storage

10. NGS Informatics Market, by Deployment Mode

  • 10.1. Cloud
    • 10.1.1. Private Cloud
    • 10.1.2. Public Cloud
  • 10.2. On-Premise

11. NGS Informatics Market, by Workflow Type

  • 11.1. Primary Analysis
    • 11.1.1. Base Calling
    • 11.1.2. Image Processing
  • 11.2. Secondary Analysis
    • 11.2.1. Alignment
    • 11.2.2. Quality Control
    • 11.2.3. Variant Calling
  • 11.3. Tertiary Analysis
    • 11.3.1. Data Mining
    • 11.3.2. Reporting And Visualization

12. NGS Informatics Market, by Application

  • 12.1. Cancer Research
    • 12.1.1. Hematologic Cancer
    • 12.1.2. Solid Tumor
  • 12.2. Genetic Disorder Research
  • 12.3. Infectious Disease
    • 12.3.1. Bacterial Genomics
    • 12.3.2. Viral Genomics
  • 12.4. Reproductive Health
    • 12.4.1. Paternity Testing
    • 12.4.2. Prenatal Screening

13. NGS Informatics Market, by End User

  • 13.1. Academic And Research Institutes
    • 13.1.1. Private Research Institutes
    • 13.1.2. Public Universities
  • 13.2. Contract Research Organizations
  • 13.3. Healthcare Providers
    • 13.3.1. Diagnostic Laboratories
    • 13.3.2. Hospitals
  • 13.4. Pharmaceutical And Biotechnology Companies
    • 13.4.1. Large Pharmaceutical Companies
    • 13.4.2. Small Biotechnology Companies

14. NGS Informatics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. NGS Informatics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. NGS Informatics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States NGS Informatics Market

18. China NGS Informatics Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Agilent Technologies Inc.
  • 19.6. Azenta Life Sciences
  • 19.7. BGI Genomics Co., Ltd.
  • 19.8. Bio-Rad Laboratories, Inc.
  • 19.9. Dassault Systemes
  • 19.10. Dnanexus Inc.
  • 19.11. DNASTAR Inc.
  • 19.12. Eagle Genomics Ltd.
  • 19.13. F. Hoffmann-La Roche Ltd.
  • 19.14. Fabric Genomics Inc.
  • 19.15. Genedata AG
  • 19.16. IBM Corporation
  • 19.17. Illumina, Inc.
  • 19.18. Partek Incorporated
  • 19.19. PerkinElmer, Inc
  • 19.20. PerkinElmer, Inc.
  • 19.21. PierianDx, Inc.
  • 19.22. Qiagen N.V.
  • 19.23. Real Time Genomics Inc.
  • 19.24. Roche Diagnostics International AG
  • 19.25. Sapio Sciences
  • 19.26. SoftGenetics, LLC
  • 19.27. Thermo Fischer Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NGS INFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NGS INFORMATICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NGS INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NGS INFORMATICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NGS INFORMATICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NGS INFORMATICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES NGS INFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA NGS INFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NGS INFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NGS INFORMATICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NGS INFORMATICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NGS INFORMATICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NGS INFORMATICS MARKET SIZE, BY CUSTOM SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NGS INFORMATICS MARKET SIZE, BY CUSTOM SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NGS INFORMATICS MARKET SIZE, BY CUSTOM SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NGS INFORMATICS MARKET SIZE, BY SUBSCRIPTION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NGS INFORMATICS MARKET SIZE, BY SUBSCRIPTION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NGS INFORMATICS MARKET SIZE, BY SUBSCRIPTION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NGS INFORMATICS MARKET SIZE, BY SEQUENCING DATA ANALYSIS TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NGS INFORMATICS MARKET SIZE, BY SEQUENCING DATA ANALYSIS TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NGS INFORMATICS MARKET SIZE, BY SEQUENCING DATA ANALYSIS TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NGS INFORMATICS MARKET SIZE, BY VISUALIZATION TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NGS INFORMATICS MARKET SIZE, BY VISUALIZATION TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NGS INFORMATICS MARKET SIZE, BY VISUALIZATION TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT AND MAPPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT AND MAPPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT AND MAPPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NGS INFORMATICS MARKET SIZE, BY ANNOTATION AND INTERPRETATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NGS INFORMATICS MARKET SIZE, BY ANNOTATION AND INTERPRETATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NGS INFORMATICS MARKET SIZE, BY ANNOTATION AND INTERPRETATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NGS INFORMATICS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NGS INFORMATICS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NGS INFORMATICS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NGS INFORMATICS MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NGS INFORMATICS MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NGS INFORMATICS MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NGS INFORMATICS MARKET SIZE, BY BASE CALLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NGS INFORMATICS MARKET SIZE, BY BASE CALLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NGS INFORMATICS MARKET SIZE, BY BASE CALLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NGS INFORMATICS MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NGS INFORMATICS MARKET SIZE, BY IMAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NGS INFORMATICS MARKET SIZE, BY IMAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NGS INFORMATICS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NGS INFORMATICS MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NGS INFORMATICS MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPORTING AND VISUALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPORTING AND VISUALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPORTING AND VISUALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEMATOLOGIC CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEMATOLOGIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEMATOLOGIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOLID TUMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOLID TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NGS INFORMATICS MARKET SIZE, BY GENETIC DISORDER RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NGS INFORMATICS MARKET SIZE, BY GENETIC DISORDER RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NGS INFORMATICS MARKET SIZE, BY GENETIC DISORDER RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NGS INFORMATICS MARKET SIZE, BY BACTERIAL GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NGS INFORMATICS MARKET SIZE, BY BACTERIAL GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NGS INFORMATICS MARKET SIZE, BY BACTERIAL GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NGS INFORMATICS MARKET SIZE, BY VIRAL GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NGS INFORMATICS MARKET SIZE, BY VIRAL GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NGS INFORMATICS MARKET SIZE, BY VIRAL GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL NGS INFORMATICS MARKET SIZE, BY PATERNITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NGS INFORMATICS MARKET SIZE, BY PATERNITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL NGS INFORMATICS MARKET SIZE, BY PATERNITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRENATAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRENATAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL NGS INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL NGS INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL NGS INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL NGS INFORMATICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL NGS INFORMATICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL NGS INFORMATICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL NGS INFORMATICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL NGS INFORMATICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL NGS INFORMATICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL NGS INFORMATICS MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL NGS INFORMATICS MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL NGS INFORMATICS MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL NGS INFORMATICS MARKET SIZE, BY SMALL BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL NGS INFORMATICS MARKET SIZE, BY SMALL BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL NGS INFORMATICS MARKET SIZE, BY SMALL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL NGS INFORMATICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS NGS INFORMATICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 290. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 304. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 308. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 309. AFRICA NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. AFRICA NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 311. AFRICA NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 312. AFRICA NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 313. AFRICA NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 314. AFRICA NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 315. AFRICA NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 316. AFRICA NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 317. AFRICA NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 318. AFRICA NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 319. AFRICA NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. AFRICA NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 321. AFRICA NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 322. AFRICA NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 323. AFRICA NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. AFRICA NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 325. AFRICA NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 326. AFRICA NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH,